ketanserin has been researched along with Diabetes Mellitus, Type 1 in 2 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Topical ketanserin is a valuable therapy for difficult-to-treat leg ulcers." | 9.12 | Healing effect of ketanserin on chronic leg ulcers in patients with diabetes. ( Cauwenbergh, G; Kharfi, M; Paquet, P; Piérard, GE; Quatresooz, P; Vroome, V, 2006) |
| "Topical ketanserin is a valuable therapy for difficult-to-treat leg ulcers." | 5.12 | Healing effect of ketanserin on chronic leg ulcers in patients with diabetes. ( Cauwenbergh, G; Kharfi, M; Paquet, P; Piérard, GE; Quatresooz, P; Vroome, V, 2006) |
| "Ketanserin was well tolerated." | 2.66 | An evaluation of ketanserin therapy for the hypertensive diabetic patient. ( Tooke, JE; Williams, SA, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quatresooz, P | 1 |
| Kharfi, M | 1 |
| Paquet, P | 1 |
| Vroome, V | 1 |
| Cauwenbergh, G | 1 |
| Piérard, GE | 1 |
| Tooke, JE | 1 |
| Williams, SA | 1 |
2 trials available for ketanserin and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Healing effect of ketanserin on chronic leg ulcers in patients with diabetes.
Topics: Administration, Cutaneous; Aged; Chronic Disease; Diabetes Mellitus, Type 1; Diabetic Foot; Double-B | 2006 |
An evaluation of ketanserin therapy for the hypertensive diabetic patient.
Topics: Blood Flow Velocity; Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Double-Bl | 1989 |